Neostigmine Methylsulfate Injection, USP, 4 mg/4 mL (1 mg/mL) syringe, packaged Supply Disruption — Nephron Sterile Compounding Ce
Neostigmine Methylsulfate Injection, USP, 4 mg/4 mL (1 mg/mL) syringe, packaged Supply Disruption — Nephron Sterile Compounding Ce is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Neostigmine Methylsulfate Injection, USP, 4 mg/4 mL (1 mg/mL) syringe, packaged; Manufacturer: Nephro
| Drug name | Neostigmine Methylsulfate Injection, USP, 4 mg/4 mL (1 mg/mL) syringe, packaged |
|---|---|
| Manufacturer | Nephron Sterile Compounding Center LLC |
| Recall/Disruption reason | Lack of Assurance of Sterility |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1271-2022 |
| Initiation date | 20220630 |
| Quantity affected | 10,700 syringes |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →